Table 1 Baseline Characteristics of ALIVE Participants by their ACE Burden
From: Adverse childhood experiences and comorbidity in a cohort of people who have injected drugs
ACE Category | |||||
|---|---|---|---|---|---|
Variable | Overall | 0–1 ACE (32.9%) | 2–4 ACEs (33.3%) | 5–9 ACEs (22.5%) | ≥10 ACEs (11.1%) |
Age: Median (IQR) | 48 (42–52) | 49 (43–53) | 49 (43–53) | 46 (41–51) | 46 (40–52) |
Sex: N (% male) | 440 (67) | 147 (69) | 158 (72) | 98 (67) | 37 (51) |
Race: N (% Black) | 530 (81) | 185 (86) | 180 (82) | 109 (74) | 56 (78) |
HIV status (% positive) | 140 (21) | 47 (21) | 43 (19) | 33 (22) | 17 (23) |
HCV status: N (% positive) | 501 (77) | 151 (71) | 182 (83) | 112 (76) | 56 (78) |
Current IDU: N (%) | 401 (61) | 127 (59) | 128 (58) | 95 (65) | 51 (71) |
Homelessness: N (%) | 164 (25) | 40 (19) | 51 (23) | 46 (31) | 27 (38) |
Income < $5,000: N (%) | 504 (79) | 164 (78) | 167 (78) | 112 (76) | 61 (86) |
Cohort 1: N (%) | 252 (39) | 88 (41) | 92 (42) | 51 (35) | 21 (29) |
Cohort 2: N (%) | 173 (26) | 58 (27) | 52 (24) | 44 (30) | 19 (26) |
Cohort 3: N (%) | 228 (35) | 68 (32) | 76 (35) | 52 (35) | 32 (44) |
0 Comorbidities: N (%) | 160 (25) | 51 (31) | 56 (35) | 36 (22) | 17 (10) |
1–2 Comorbidities: N (%) | 358 (55) | 123 (34) | 116 (32) | 82 (22) | 37 (10) |
≥3 Comorbidities: N (%) | 126 (20) | 38 (30) | 43 (34) | 27 (21) | 18 (14) |